10-Q: Hydrofarm Q2 Sales Plunge 28%, Gross Profit Halves

Hydrofarm Holdings Group reported a significant decline in second-quarter net sales and gross profit, continuing restructuring efforts to combat industry oversupply and reduce costs.

Summary

• Net sales for the three months ended June 30, 2025, decreased by 28.4% to $39.2 million, and by 26.8% to $79.8 million for the six months ended June 30, 2025, compared to the same periods in 2024.
• Gross profit for the three months ended June 30, 2025, fell by 74.3% to $2.8 million, with gross profit margin decreasing to 7.1% from 19.8% in the prior year period.
• Net loss for the three months ended June 30, 2025, improved to $16.9 million from $23.5 million in the prior year period, and to $31.2 million from $36.1 million for the six months ended June 30, 2025.
• The company initiated a 2025 Restructuring Plan in the second quarter of 2025, incurring $3.3 million in non-cash inventory write-downs, with an anticipated additional $2 million in charges and over $3 million in annual cost savings.
• Cash and cash equivalents decreased by $15.1 million to $11.0 million as of June 30, 2025, from $26.1 million at December 31, 2024.
• A 1-for-10 reverse stock split was effected on February 12, 2025, to maintain Nasdaq listing compliance.

Sentiment

Score: 2

Explanation: The company reported significant declines in sales and gross profit, indicating severe market headwinds and operational challenges. While net loss improved, it remains substantial, and cash burn from operations is a concern. Ongoing restructuring efforts highlight the depth of the issues, and the reduction in credit facility limits points to tighter liquidity. The overall financial health appears weak, with no clear signs of immediate recovery based on the reported figures.

Positives

• Net loss decreased by 28.1% in the three months ended June 30, 2025, and 13.3% for the six months ended June 30, 2025, compared to the prior year periods.
• Selling, general and administrative (SG&A) expenses decreased by 13.5% in the three months ended June 30, 2025, and 11.2% for the six months ended June 30, 2025, due to cost-saving and restructuring initiatives.
• Interest expense decreased by 11.0% in the three months ended June 30, 2025, and 12.6% for the six months ended June 30, 2025, primarily due to lower debt outstanding and lower variable interest rates on the Term Loan.
• A $4.5 million prepayment on the Term Loan was made in the second quarter of 2025, reducing future quarterly principal installments to zero.
• The company remains in compliance with all debt covenants as of June 30, 2025.

Negatives

• Net sales significantly decreased by 28.4% in the three months ended June 30, 2025, and 26.8% for the six months ended June 30, 2025, primarily due to a reduction in product volume and mix, and a decrease in price.
• Gross profit declined sharply by 74.3% in the three months ended June 30, 2025, and 55.6% for the six months ended June 30, 2025, impacted by lower net sales, a lower proportion of proprietary brand products, and restructuring charges.
• Gross profit margin decreased to a low 7.1% in the three months ended June 30, 2025, from 19.8% in the prior year period.
• Cash and cash equivalents saw a substantial decrease of $15.1 million in the first six months of 2025, with net cash used in operating activities at $10.0 million.
• The maximum commitment amount under the Revolving Credit Facility was reduced from $35 million to $22 million.
• The company incurred $3.3 million in non-cash inventory write-downs in the second quarter of 2025 as part of the new restructuring plan.

Risks

• Continued adverse impact from agricultural oversupply and decreasing prices in the market, which have materially impacted sales and may continue to do so.
• Potential for future charges associated with the impairment of long-lived assets, inventory allowances, purchase commitment losses, and accounts receivable reserves.
• Uncertainty regarding the company's liquidity and ability to generate sufficient cash flow from operating activities.
• Challenges in meeting the continued listing standards of The Nasdaq Capital Market.
• Potential dilution that may result from equity financings while stock prices are depressed.
• Negative impact on demand due to the extended period to enact reform of U.S. federal regulations, including cannabis rescheduling, leading cannabis operators to reduce investments.
• Adverse effects of hydroponic retail store closings and associated accounts receivable allowances.
• Potential tariffs or a global trade war could increase the cost of products, adversely impacting competitiveness and financial results.
• Restructuring activities may increase expenses and cash expenditures, and may not have the intended effects.
• Dependence on a limited base of key suppliers for certain products.
• Volatility of the price of the common stock.

Future Outlook

The company anticipates additional restructuring charges of approximately $2 million and annual cost savings in excess of $3 million plus additional working capital benefits from the 2025 Restructuring Plan. Management continues to evaluate its product portfolio and supply chain to improve efficiency, lower costs, and reduce its operational footprint, including potential sales of excess owned land and contract manufacturing arrangements. The company believes current cash flows and borrowing availability will be adequate for the next twelve months, but cannot guarantee sufficient cash flow or future borrowings.

Management Comments

• We have experienced adverse financial results which we believe are primarily a result of an agricultural oversupply impacting our market and resulting in a decrease in indoor and outdoor cultivation.
• We believe demand for our products has been negatively impacted by the extended period to enact reform of U.S. federal regulations, including cannabis rescheduling, which have been slow to develop and possibly leading cannabis operators to reduce investments in our products, particularly durable goods.
• We are closely monitoring the recent tariff and trade policy actions changes taken by the United States and foreign governments. The situation remains fluid due to the rapidly changing global trade environment, and we are evaluating the potential implications of these actions on our business including net sales and profitability.
• We anticipate the 2025 Restructuring Plan and related actions may result in additional restructuring charges of approximately $2 million, and annual cost savings in excess of $3 million plus additional working capital benefits.
• We believe that our cash flows from operating activities, combined with current cash levels and borrowing availability under the Revolving Credit Facility, will be adequate to support our ongoing operations, and to fund debt service requirements, capital expenditures, lease obligations and working capital needs through the next twelve months of operations.
• If necessary, we believe that we could supplement our cash position through additional asset sales or divestiture of one or more of our brands or lines of business.

Industry Context

The company's performance is significantly impacted by an agricultural oversupply, particularly affecting indoor and outdoor cultivation, and slow progress in U.S. federal cannabis regulation reform, which has led cannabis operators to reduce investments. These factors contribute to declining demand for hydroponics equipment and supplies. The company also notes the fluid global trade environment and potential impact of tariffs on product costs.

Corporate Governance

Stakeholder Impact

• Shareholders: Experience significant dilution from the reverse stock split (though value is theoretically unchanged, it often signals distress). Face continued losses and uncertainty regarding future profitability and stock price volatility. Potential for further dilution if equity financings occur.
• Employees: Headcount reductions are part of the 2025 Restructuring Plan, indicating potential job losses.
• Customers: May experience changes in product availability due to portfolio reduction and operational footprint changes.
• Suppliers: Impacted by product portfolio reduction and potential changes in supply chain strategy (e.g., contract manufacturing).
• Creditors: The company remains in compliance with debt covenants, and a Term Loan prepayment was made, which is positive. However, reduced Revolving Credit Facility limits and ongoing losses indicate increased risk.

Next Steps

• Continue to evaluate product portfolio and supply chain to improve efficiency, lower costs, and reduce operational footprint.
• Evaluate other opportunities to sell excess owned land not currently used in operations to supplement cash position.
• Evaluate potential contract manufacturing or other outsourcing arrangements.
• Possible execution of additional restructuring plan actions depending on the length and severity of industry and market conditions.
• The company is currently evaluating the impact of ASU No. 2023-09 (Income Taxes) and ASU 2024-03 (Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures) on its financial statements.

Key Dates

Recommendation

The company's financial performance is severely deteriorating, marked by a substantial decline in net sales and a dramatic drop in gross profit margin. While net loss has narrowed, it remains significant, and the company is burning cash from operations. Ongoing restructuring efforts, including inventory write-downs and headcount reductions, signal deep-seated operational challenges. The reduction in the Revolving Credit Facility's borrowing limit further highlights liquidity concerns. The industry faces persistent oversupply and slow regulatory reform, which are significant headwinds. Given the poor financial results, continued cash burn, and uncertain market conditions, the stock carries high risk and is likely to face further downward pressure.

Keywords

Hydrofarm Holdings Group, HYFM, SEC Filing, 10-Q, Quarterly Report, Hydroponics, Controlled Environment Agriculture, CEA, Grow Lights, Nutrients, Restructuring, Inventory Write-downs, Reverse Stock Split, Nasdaq Listing, Agricultural Oversupply, Cannabis Industry, Financial Results